Wednesday - April 24, 2024
AMCP Submits Comments to FDA on BsUFA II Reauthorization
October 19, 2016
ALEXANDRIA, Va., Oct. 19 -- The Academy of Managed Care Pharmacy issued the text of the following letter:

Food and Drug Administration

Division of Dockets Management (HFA-305)

Department of Health and Human Services

5630 Fishers Lane

Room 1061

Rockville, MD 20852

Re: Biosimilar User Fee Act: Public Meeting; Request for Comments

[FDA-2015-N-3326-0012]

Dear Sir or . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products